Serious long-term health consequences of Q-fever and Legionnaires' disease

van Loenhout, Joris;van Tiel, Hein H.M.M.;van den Heuvel, Jet;Vercoulen, Jan H.;Hautvast, Jeannine L.A.;et.al.
(2014) Journal of Infection — Vol. 68, n° 6, p. 527-533 (2014)

Files

JorisVLSerious.pdf
  • Restricted Access
  • Adobe PDF
  • 235.58 KB

Details

Authors
  • van Loenhout, Jorisorcid-logoUCLouvain
    Author
  • van Tiel, Hein H.M.M.
    Author
  • van den Heuvel, Jet
    Author
  • Vercoulen, Jan H.
    Author
  • Hautvast, Jeannine L.A.
    Author
Show more
Abstract
Background: We assessed and compared the long-term health status of Q-fever patients and patients with Legionnaires’ disease. Methods: Q-fever patients and patients with Legionnaires’ disease fulfilling the Dutch notification criteria filled out a questionnaire at one year after onset of illness. The proportion of patients with an abnormal score was calculated for 12 health status subdomains and mean scores for the most relevant subdomains were compared between the patient groups. Results: We included 309 Q-fever patients and 190 patients with Legionnaires’ disease in the study. A large proportion of the two patient groups was negatively affected on many of the subdomains, especially ‘Fatigue’, ‘General Quality of Life’ and ‘Role Physical’. We assessed health status of the patient groups using a multivariate regression analysis and found no significant difference for ‘Fatigue’ and ‘General Quality of Life’. Only for the subdomain ‘Role Physical’, Q-fever patients scored significantly worse compared to patients with Legionnaires’ disease.
Affiliations
  • Department of Primary and Community CareRadboud University Nijmegen

Citations

van Loenhout, J., van Tiel, H. H. M. M., van den Heuvel, J., Vercoulen, J. H., Bor, H., van der Velden, K., Paget, W. J., & Hautvast, J. L. A. (2014). Serious long-term health consequences of Q-fever and Legionnaires’ disease. Journal of Infection, 68(6), 527-533. https://doi.org/10.1016/j.jinf.2014.01.004 (Original work published 2014)